Protection from septic shock subsequent to injury by dsRNAs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5763417
SERIAL NO

08469625

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The use of dsRNA for use in the reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for various clinical phases of the biological continuous of an acquired immune deficient state are described. Protection from the toxic effects associated with increased TNF levels is described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HEMISPHERX BIOPHARMA INCPHILADELPHIA PA 19103

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Einck, Leo McLean, VA 10 118

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation